PreciseDx: Sponsored collaboration will focus on evaluating the ability of PreciseBreast™ to accurately predict breast cancer recurrence for those patients with TNBC  NEW YORK, April 2, 2024 /PRNewswire/ -- PreciseDx®, a leading...